These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33207023)

  • 41. The Affect of Lifestyle on Bone Mineral Density and Bone Turnover in Young Women.
    Motooka N; Matsuo H
    Kobe J Med Sci; 2020 Feb; 65(4):E124-E131. PubMed ID: 32201427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency.
    Miyaoka D; Imanishi Y; Ohara M; Hayashi N; Nagata Y; Yamada S; Mori K; Emoto M; Inaba M
    Osteoporos Int; 2019 Jan; 30(1):241-249. PubMed ID: 30187112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biochemical markers of bone turnover and their relation to forearm bone mineral density in persons of Pakistani and Norwegian background living in Oslo, Norway: The Oslo Health Study.
    Holvik K; Meyer HE; Søgaard AJ; Selmer R; Haug E; Falch JA
    Eur J Endocrinol; 2006 Nov; 155(5):693-9. PubMed ID: 17062885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
    Nenonen A; Cheng S; Ivaska KK; Alatalo SL; Lehtimäki T; Schmidt-Gayk H; Uusi-Rasi K; Heinonen A; Kannus P; Sievänen H; Vuori I; Väänänen HK; Halleen JM
    J Bone Miner Res; 2005 Oct; 20(10):1804-12. PubMed ID: 16355501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
    Szentpetery A; McKenna MJ; Murray BF; Ng CT; Brady JJ; Morrin M; Radovits B; Veale DJ; Fitzgerald O
    J Rheumatol; 2013 May; 40(5):653-62. PubMed ID: 23457381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct‑acting antiviral treatment decreases serum undercarboxylated osteocalcin in male patients with chronic hepatitis C.
    Ichikawa T; Yamashima M; Yamamichi S; Koike M; Nakano Y; Honda T; Yajima H; Miyazaki O; Kuribayashi Y; Ikeda T; Okamura T; Nakao K
    Biomed Rep; 2022 Nov; 17(5):84. PubMed ID: 36185786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women.
    Atalay S; Elci A; Kayadibi H; Onder CB; Aka N
    Ann Lab Med; 2012 Jan; 32(1):23-30. PubMed ID: 22259775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Burshell AL; Möricke R; Correa-Rotter R; Chen P; Warner MR; Dalsky GP; Taylor KA; Krege JH
    Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tartrate-resistant acid phosphatase isoform 5a as an inflammation marker in end-stage renal disease.
    Janckila AJ; Lederer ED; Price BA; Yam LT
    Clin Nephrol; 2009 Apr; 71(4):387-96. PubMed ID: 19356371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between bone turnover markers and the heel stiffness index measured by quantitative ultrasound in middle-aged and elderly Japanese men.
    Nishimura T; Arima K; Abe Y; Kanagae M; Mizukami S; Okabe T; Tomita Y; Goto H; Horiguchi I; Aoyagi K
    Medicine (Baltimore); 2018 Feb; 97(8):e9962. PubMed ID: 29465590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
    Chen H; Cui Y; Xing C; Purrunsing Y; Zha X; Shen C; Zeng M; Yang G; Yu X; Zhang L; Jiang Y; Shen Z; Ma H; Yin C; Li Y; Wang N
    Int Urol Nephrol; 2018 Dec; 50(12):2279-2288. PubMed ID: 30361964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M; Fukunaga M; Ohtawa T; Harada T
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitamins K and D deficiency in severe motor and intellectually disabled patients.
    Sakai T; Shirai T; Oishi T
    Brain Dev; 2021 Feb; 43(2):200-207. PubMed ID: 33139126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone status in adults with early-onset juvenile idiopathic arthritis following 1-year anti-TNFα therapy and discontinuation of glucocorticoids.
    Brabnikova Maresova K; Jarosova K; Pavelka K; Stepan JJ
    Rheumatol Int; 2013 Aug; 33(8):2001-7. PubMed ID: 23370856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening osteoporotic femoral neck without measuring bone mineral density with the use of tartrate resistant acid phosphatase-5b and serum-creatinine-to-cystatin C ratio in Japanese postmenopausal women.
    Yoshii I; Chijiwa T; Sawada N
    J Orthop Sci; 2020 Jul; 25(4):671-676. PubMed ID: 31337577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determining the association between hypertension and bone metabolism markers in osteoporotic patients.
    Hu Z; Yang K; Hu Z; Li M; Wei H; Tang Z; Chen B; Su C; Cai D; Xu J
    Medicine (Baltimore); 2021 Jun; 100(24):e26276. PubMed ID: 34128860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
    Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
    Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preventative effects of metformin on glucocorticoid-induced osteoporosis in rats.
    Zhao J; Li Y; Zhang H; Shi D; Li Q; Meng Y; Zuo L
    J Bone Miner Metab; 2019 Sep; 37(5):805-814. PubMed ID: 30706148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated serum interleukin-7 level in idiopathic steroid-sensitive nephrotic syndrome.
    Kanai T; Shiraishi H; Yamagata T; Ito T; Odaka J; Saito T; Aoyagi J; Momoi MY
    Pediatr Int; 2011 Dec; 53(6):906-9. PubMed ID: 21486379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.